Feasibility and pharmacokinetic study of bendamustine hydrochloride in combination with rituximab in relapsed or refractory aggressive B cell non-Hodgkin's lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/21624007

Download in:

View as

General Info

PMID
21624007